SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 5 of 100
Health
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By
Ryan Hogg
February 4, 2025
Health
The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By
Lindsey Leake
February 4, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Lindsey Leake
February 3, 2025
Health
Ozempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity
By
The Associated Press
,
Kenya Hunter
and
Linley Sanders
January 31, 2025
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By
Bloomberg
and
Gerry Smith
January 31, 2025
Health
Cigna plans to limit out-of-pocket drug costs for U.S. patients
By
Bloomberg
and
John Tozzi
January 30, 2025
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By
Lindsey Leake
January 29, 2025
Finance
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise
By
Greg McKenna
January 24, 2025
Mind
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
By
Beth Greenfield
January 23, 2025
Health
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By
Lindsey Leake
January 23, 2025
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By
Lindsey Leake
January 22, 2025
Success
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
By
Ryan Hogg
January 20, 2025
Retail
Walgreens accused of filling millions of illegitimate prescriptions, including for opioids
By
The Associated Press
January 18, 2025
Leadership
Novo Nordisk CEO attends crisis talks with Danish PM amid Donald Trump Greenland threats
By
Ryan Hogg
January 17, 2025
Retail
Walgreens replaced its refrigerator doors with digitized ad-laden glass. It might become a $200 million debacle
By
Sydney Lake
January 17, 2025
Most Popular
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
AI
Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
By
Nick Lichtenberg